Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type

Tumor Biology

Volumn 32, Issue 5, 2011, Pages 913-920

  Zhai, Linzhu ^a,b   Zhao, Yuanyuan ^b   Ye, Sheng ^c   Huang, He ^b   Tian, Ying ^b   Wu, Qiuliang ^b   Lin, Hanliang ^c   Lin, Tongyu ^b  

^a University of Traditional Chinese Medicine   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

FOXP1; Histology; MALT lymphoma; PIK3CA; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; MITOXANTRONE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE 3 KINASE CATALYTIC ALPHA POLYPEPTIDE; PREDNISONE; RITUXIMAB; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP1; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ARTICLE; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CELL NUCLEUS; CONTROLLED STUDY; FEMALE; GASTRIC MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION;

EID: 80052332283     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0192-3     Document Type: Article

References (38)

1. The Non-Hodgkin's Lymphoma Classification Project 1997 A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma Blood 89 11 3909 3918
2. Cavalli F, Isaacson PG, Gascoyne RD, Zucca E. MALT lymphomas. Hematology Am Soc Hematol Educ Program 2004;241-258
3. M Raderer B Streubel S Woehrer A Puespoek U Jaeger M Formanek A Chott 2005 High relapse rate in patients with MALT lymphoma warrants lifelong follow-up Clin Cancer Res 11 9 3349 3352 15867234 10.1158/1078-0432.CCR-04-2282 (Pubitemid 40627886)
4. P Starostik J Patzner A Greiner S Schwarz J Kalla G Ott HK Muller-Hermelink 2002 Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways Blood 99 1 3 9 11756145 10.1182/blood.V99.1.3 1:CAS:528:DC%2BD38XivFyqtQ%3D%3D (Pubitemid 34532956)
5. B Streubel U Vinatzer A Lamprecht M Raderer A Chott 2005 T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma Leukemia 19 4 652 658 15703784 1:CAS:528: DC%2BD2MXjs1OltbY%3D (Pubitemid 40521171)
6. AC Wotherspoon TM Finn PG Isaacson 1995 Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue Blood 85 8 2000 2004 7718871 1:CAS:528:DyaK2MXltVSrtb8%3D
7. J Krugmann A Tzankov S Dirnhofer F Fend D Wolf R Siebert P Probst M Erdel 2005 Complete or partial trisomy 3 in gastro-intestinal MALT lymphomas co-occurs with aberrations at 18q21 and correlates with advanced disease stage: a study on 25 cases World J Gastroenterol 11 46 7384 7385 16437648
8. J Dierlamm S Pittaluga I Wlodarska M Stul J Thomas M Boogaerts L Michaux A Driessen C Mecucci JJ Cassiman C De Wolf-Peeters H Van den Berghe 1996 Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features Blood 87 1 299 307 8547655 1:CAS:528:DyaK28Xit1Shsw%3D%3D (Pubitemid 26011844)
9. SL Barrans JA Fenton A Banham RG Owen AS Jack 2004 Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome Blood 104 9 2933 2935 15238418 10.1182/blood-2004-03- 1209 1:CAS:528:DC%2BD2cXpslKju7w%3D (Pubitemid 39434982)
10. AH Banham JM Connors PJ Brown JL Cordell G Ott G Sreenivasan P Farinha DE Horsman RD Gascoyne 2005 Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma Clin Cancer Res 11 3 1065 1072 15709173 1:CAS:528:DC%2BD2MXht1yntrk%3D (Pubitemid 40175755)
11. I Akagi M Miyashita H Makino T Nomura N Hagiwara K Takahashi K Cho T Mishima O Ishibashi T Ushijima T Takizawa T Tajiri 2009 Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma Int J Oncol 34 3 767 775 19212681 10.3892/ijo-00000202 1:CAS:528: DC%2BD1MXjs1Kgtr8%3D
12. Y Wang GB Kristensen A Helland JM Nesland AL Borresen-Dale R Holm 2005 Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas Am J Clin Pathol 124 3 392 401 16191507 10.1309/BL7EMW66LQX6GFRP 1:CAS:528:DC%2BD2MXhtVCks73K (Pubitemid 41232925)
13. AD Zelenetz TT Chen R Levy 1991 Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell J Exp Med 173 1 197 207 1898660 10.1084/jem.173.1.197 1:CAS:528:DyaK3MXmtVegtA%3D%3D
14. PM Kluin JH van Krieken K Kleiverda HC Kluin-Nelemans 1990 Discordant morphologic characteristics of B-cell lymphomas in bone marrow and lymph node biopsies Am J Clin Pathol 94 1 59 66 2360564 1:STN:280:DyaK3c3pslSqtg%3D%3D (Pubitemid 20206896)
15. C McCormick E Philp J Mansi N Livni K McCarthy 1994 Clonal analysis of three morphologically distinct lymphomas occurring in the same patient J Clin Pathol 47 11 1038 1042 7829681 10.1136/jcp.47.11.1038 1:STN:280: DyaK2M7jtVOmsw%3D%3D
16. JK Chan 2001 The new World Health Organization classification of lymphomas: the past, the present and the future Hematol Oncol 19 4 129 150 11754390 10.1002/hon.660 1:STN:280:DC%2BD38%2FgtFCnug%3D%3D (Pubitemid 34072434)
17. AJ Ferreri M Freschi S Dell'Oro E Viale E Villa M Ponzoni 2001 Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-cell gastric lymphomas Am J Surg Pathol 25 1 95 102 11145257 10.1097/00000478-200101000-00011 1:STN:280:DC%2BD3M%2Fnt1GksA%3D%3D (Pubitemid 32001838)
18. D de Jong H Boot P van Heerde GA Hart BG Taal 1997 Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance Gastroenterology 112 5 1466 1474 9136823 10.1016/S0016-5085(97)70026-X (Pubitemid 27181369)
19. ED Hsi A Eisbruch JK Greenson TP Singleton CW Ross B Schnitzer 1998 Classification of primary gastric lymphomas according to histologic features Am J Surg Pathol 22 1 17 27 9422312 10.1097/00000478-199801000-00003 1:STN:280:DyaK1c%2Fot1Oktw%3D%3D (Pubitemid 28016748)
20. A Rohatiner F d'Amore B Coiffier D Crowther M Gospodarowicz P Isaacson TA Lister A Norton P Salem M Shipp, et al. 1994 Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma Ann Oncol 5 (5 397 400 8075046 1:STN:280:DyaK2czlsFamtQ%3D%3D (Pubitemid 24159642)
21. E Zucca A Conconi E Pedrinis S Cortelazzo T Motta MK Gospodarowicz BJ Patterson AJ Ferreri M Ponzoni L Devizzi R Giardini G Pinotti C Capella PL Zinzani S Pileri A Lopez-Guillermo E Campo A Ambrosetti L Baldini F Cavalli 2003 Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue Blood 101 7 2489 2495 12456507 10.1182/blood-2002-04-1279 1:CAS:528: DC%2BD3sXivVWgtbo%3D (Pubitemid 36857603)
22. CP Hans DD Weisenburger TC Greiner RD Gascoyne J Delabie G Ott HK Muller-Hermelink E Campo RM Braziel ES Jaffe Z Pan P Farinha LM Smith B Falini AH Banham A Rosenwald LM Staudt JM Connors JO Armitage WC Chan 2004 Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray Blood 103 1 275 282 14504078 10.1182/blood-2003-05-1545 1:CAS:528:DC%2BD2cXhsFGhsA%3D%3D (Pubitemid 38029949)
23. JJ Hoefnagel MM Mulder E Dreef PM Jansen ST Pals CJ Meijer R Willemze MH Vermeer 2006 Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma Mod Pathol 19 9 1270 1276 16778825 10.1038/modpathol.3800650 1:CAS:528:DC%2BD28XotlCgu7w%3D (Pubitemid 44268198)
24. S Kang AG Bader PK Vogt 2005 Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic Proc Natl Acad Sci USA 102 3 802 807 15647370 10.1073/pnas.0408864102 1:CAS:528:DC%2BD2MXis1Cqsb0%3D (Pubitemid 40282746)
25. Y Baohua Z Xiaoyan Z Tiecheng Q Tao S Daren 2008 Mutations of the PIK3CA gene in diffuse large B cell lymphoma Diagn Mol Pathol 17 3 159 165 18382359 10.1097/PDM.0b013e31815d0588
26. M Rudelius S Pittaluga S Nishizuka TH Pham F Fend ES Jaffe L Quintanilla-Martinez M Raffeld 2006 Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma Blood 108 5 1668 1676 16645163 10.1182/blood-2006-04-015586 1:CAS:528:DC%2BD28Xpt1SltbY%3D (Pubitemid 44316136)
27. AV Miletic AN Anzelon-Mills DM Mills SA Omori IM Pedersen DM Shin JV Ravetch S Bolland HC Morse 3rd RC Rickert 2010 Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases J Exp Med 207 11 2407 2420 20956547 10.1084/jem.20091962 1:CAS:528:DC%2BC3cXhsVSktLzK
28. SH Kuo PY Yeh LT Chen MS Wu CW Lin KH Yeh YS Tzeng JY Chen PN Hsu JT Lin AL Cheng 2008 Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma Blood 112 7 2927 2934 18628489 10.1182/blood-2008-02-137513 1:CAS:528:DC%2BD1cXht1SrtbzJ
29. B Karakas KE Bachman BH Park 2006 Mutation of the PIK3CA oncogene in human cancers Br J Cancer 94 4 455 459 16449998 10.1038/sj.bjc.6602970 1:CAS:528:DC%2BD28Xhs1ers70%3D (Pubitemid 43289745)
30. M Bousquet C Recher C Queleen C Demur B Payrastre P Brousset 2005 Assessment of somatic mutations in phosphatidylinositol 3-kinase gene in human lymphoma and acute leukaemia Br J Haematol 131 3 411 413 16225664 10.1111/j.1365-2141.2005.05784.x 1:CAS:528:DC%2BD2MXht1yisbzK (Pubitemid 43899676)
31. J Woenckhaus K Steger E Werner I Fenic U Gamerdinger T Dreyer U Stahl 2002 Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma J Pathol 198 3 335 342 12375266 10.1002/path.1207 1:CAS:528:DC%2BD38XovFarsL0%3D (Pubitemid 35277384)
32. LZ Zhai Y Huang SS Wang YB Cao J Xiao X Fu S Ye CC Guo Y Tian TY Lin 2008 PIK3CA, BCL-6, MLL and FOXP1 in the transformation and prognosis of MALT lymphoma [abstract] J Clin Oncol 26 May 20 suppl abstr 8577
33. P Carlsson M Mahlapuu 2002 Forkhead transcription factors: key players in development and metabolism Dev Biol 250 1 1 23 12297093 10.1006/dbio.2002.0780 1:CAS:528:DC%2BD38XntVyms70%3D
34. S Nakamura H Ye CM Bacon A Goatly H Liu AH Banham R Ventura T Matsumoto M Iida Y Ohji T Yao M Tsuneyoshi MQ Du 2007 Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation Gut 56 10 1358 1363 17525089 10.1136/gut.2007.123729 (Pubitemid 47517827)
35. SL Han XL Wu L Wan QQ Zeng JL Li Z Liu 2009 FOXP1 expression predicts polymorphic histology and poor prognosis in gastric mucosa-associated lymphoid tissue lymphomas Dig Surg 26 2 156 162 19365123 10.1159/000212058 1:CAS:528:DC%2BD1MXmtFChsrg%3D
36. X Sagaert P de Paepe L Libbrecht V Vanhentenrijk G Verhoef J Thomas I Wlodarska C De Wolf-Peeters 2006 Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma J Clin Oncol 24 16 2490 2497 16636337 10.1200/JCO.2006.05.6150 1:CAS:528:DC%2BD28XmtVOmtrs%3D (Pubitemid 46630625)
37. P Farinha RD Gascoyne 2005 Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma J Clin Oncol 23 26 6370 6378 16155022 10.1200/JCO.2005.05.011 1:CAS:528:DC%2BD2MXhtFWntbbE (Pubitemid 46218849)
38. A Goatly CM Bacon S Nakamura H Ye I Kim PJ Brown A Ruskone-Fourmestraux P Cervera B Streubel AH Banham MQ Du 2008 FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control Mod Pathol 21 7 902 911 18487996 10.1038/modpathol.2008. 74 1:CAS:528:DC%2BD1cXnsFOgs7k%3D (Pubitemid 351896666)